Successful collaboration in Malaysia and Chile

Virtual Signing Ceremony between Yong Tai Berhad and Shenzhen Kangtai Biological Products Co. Ltd-2019-nCoV Vaccine (Vero Cell) Phase III Clinical and Product Procurement Agreement was held on Feb,9th ,2021.

Virtual Signing Ceremony between AMSISA and Shenzhen Kangtai Biological Products Co. Ltd-2019-nCoV Vaccine (Vero Cell) Phase III Clinical and Product Procurement Agreement was held on May,24th 2021.

Cooperated with the Merck and imported the first full cycle vaccine production technology in 1990s, being the pioneer in China vaccine industry. In the last 30 years, BioKangtai has produced over 1 billion doses of Hep B vaccines, contributed a lot to the public health in China.

Cooperated with the Intravacc of Netherland in the Inactivated Poliomyelitis Vaccine, Sabin Strains, working on the local production of this important vaccine.

Cooperated with the Sanofi Pastuer in the full cycle technology transfer in the human rabies vaccine, the second full cycle vaccine production transfer in China’s history.

Cooperated with the AstraZeneca in the adenovirus covid-19 vaccine in the early stage of the pandemic, 2020 as the only strategic partner with AZ in China. Has passed the EUA in Indonesia, 2021.

Cooperated with USA NIH in the rotavirus vaccine products, focusing on the breakthrough in rotavirus vaccine studies in China.